Table 2.
Subgroup analyses after stratification for mean age, population, geographic area, and follow-up length
| N | SPPB 0–3 vs. SPPB 10–12 | N | SPPB 4–6 vs. SPPB 10–12 | N | SPPB 7–9 vs. SPPB 10–12 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | OR (95% CI) | I 2% | p | 17 | OR (95% CI) | I 2% | p | 17 | OR (95% CI) | I 2% | p | |
| Mean age | 0.37 | 0.19 | 0.24 | |||||||||
| ≤75 | 7 | 3.54 (2.81–4.46) | 0 | 8 | 2.40 (1.97–2.93) | 0 | 8 | 1.65 (1.27–2.16) | 59 | |||
| >75 | 8 | 3.12 (2.67–3.65) | 0 | 9 | 2.04 (1.79–2.33) | 0 | 9 | 1.38 (1.22–1.57) | 0 | |||
| Population | 0.36 | 0.32 | 0.91 | |||||||||
| General population | 10 | 3.27 (2.86–3.75) | 0 | 11 | 2.22 (1.98–2.49) | 0 | 11 | 1.48 (1.32–1.65) | 9 | |||
| Outpatients | 2 | 2.53 (1.56–4.12) | 0 | 3 | 1.45 (0.83–2.52) | 14 | 3 | 1.48 (0.54–4.08) | 80 | |||
| Hospitalized | 3 | 4.93(2.18–11.14) | 0 | 3 | 1.94 (0.85–4.41) | 0 | 3 | 1.23 (0.53–2.85) | 0 | |||
| Geographic area | 0.40 | 0.24 | 0.37 | |||||||||
| Europe | 11 | 3.44 (2.91–4.07) | 0 | 11 | 2.02 (1.74–2.33) | 3 | 11 | 1.42 (1.25–1.60) | 0 | |||
| Asia | 1 | 1.15(0.13–10.54) | – | 1 | 3.94(1.34–11.56) | – | 1 | 1.95 (0.82–4.63) | – | |||
| North America | 3 | 3.01(2.46–3.69) | 0 | 5 | 2.34 (1.96–2.80) | 0 | 5 | 1.79 (1.26–2.55) | 73 | |||
| Follow-up length | 0.49 | 0.30 | 0.94 | |||||||||
| ≤1 year | 3 | 4.22 (1.97–9.02) | 0 | 4 | 1.42 (0.65–3.10) | 0 | 4 | 1.51 (0.50–4.59) | 64 | |||
| >1 year | 12 | 3.22 (2.83–3.69) | 0 | 13 | 2.16 (1.94–2.41) | 0 | 13 | 1.45 (1.32–1.60) | 0 | |||
| 0.72 | 0.77 | 0.84 | ||||||||||
| ≤5 years | 10 | 3.30 (2.82–3.86) | 0 | 11 | 2.13 (1.86–2.43) | 0 | 11 | 1.53 (1.23–1.91) | 49 | |||
| >5 years | 5 | 3.13 (2.48–3.96) | 5 | 6 | 2.22 (1.73–2.85) | 35 | 6 | 1.49 (1.27–1.75) | 0 | |||
SPPB Short Physical Performance Battery, N number of studies analyzed for subgroup